Abstract
This study was designed to evaluate and compare the inhibitory property of extracts of Andrographis paniculata leaves [methanolic (AP1), hydroalcoholic (AP2), successive water (AP3)] and non-leaves [methanolic (AP4), hydroalcoholic (AP5), successive water (AP6)] towards inflammatory mediators (NO, IL-1 beta, IL-6, TNF alpha, PGE2, TXB2 and LTB4). Stimulant induced J774A.1 murine macrophages and HL-60 promyelocytic leukemic cells were used to study the inhibitory potential of extracts of A. paniculata on inflammatory mediators. Results revealed that AP1 and AP4 exhibited inhibitory effect on all the inflammatory mediators excluding PGE2 and TNF-alpha. AP2 and AP5 exhibited inhibitory effect towards IL-1 beta, TXB2 and did not show inhibitory effect towards other mediators. However, AP3 and AP6 failed to show inhibitory activity against any of the inflammatory mediators at the tested concentrations. Further, we observed that the magnitude of inhibitory effect displayed by A. paniculata extracts depends on the andrographolide content, although, it does not appear to influence the inhibitory effect towards LTB4 production.
Keywords: Andrographis paniculata, leaves, non-leaves, inflammatory mediators (NO, IL-1 beta, IL-6, LTB4, PGE2, TNF-alpha and TXB2)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:In Vitro Comparative Evaluation of Non-Leaves and Leaves Extracts of Andrographis paniculata on Modulation of Inflammatory Mediators
Volume: 11 Issue: 2
Author(s): C. V. Chandrasekaran, B. Murali, M. Deepak and Amit Agarwal
Affiliation:
Keywords: Andrographis paniculata, leaves, non-leaves, inflammatory mediators (NO, IL-1 beta, IL-6, LTB4, PGE2, TNF-alpha and TXB2)
Abstract: This study was designed to evaluate and compare the inhibitory property of extracts of Andrographis paniculata leaves [methanolic (AP1), hydroalcoholic (AP2), successive water (AP3)] and non-leaves [methanolic (AP4), hydroalcoholic (AP5), successive water (AP6)] towards inflammatory mediators (NO, IL-1 beta, IL-6, TNF alpha, PGE2, TXB2 and LTB4). Stimulant induced J774A.1 murine macrophages and HL-60 promyelocytic leukemic cells were used to study the inhibitory potential of extracts of A. paniculata on inflammatory mediators. Results revealed that AP1 and AP4 exhibited inhibitory effect on all the inflammatory mediators excluding PGE2 and TNF-alpha. AP2 and AP5 exhibited inhibitory effect towards IL-1 beta, TXB2 and did not show inhibitory effect towards other mediators. However, AP3 and AP6 failed to show inhibitory activity against any of the inflammatory mediators at the tested concentrations. Further, we observed that the magnitude of inhibitory effect displayed by A. paniculata extracts depends on the andrographolide content, although, it does not appear to influence the inhibitory effect towards LTB4 production.
Export Options
About this article
Cite this article as:
V. Chandrasekaran C., Murali B., Deepak M. and Agarwal Amit, In Vitro Comparative Evaluation of Non-Leaves and Leaves Extracts of Andrographis paniculata on Modulation of Inflammatory Mediators, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2012; 11 (2) . https://dx.doi.org/10.2174/187152312803305731
DOI https://dx.doi.org/10.2174/187152312803305731 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Limonin, A Citrus Limonoid, had no Apparent Effect on Cognitive Dysfunction in Mice with Chronic Cerebral Hypoperfusion
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Genetic Insights into Sepsis: What have we Learned and How will it Help?
Current Pharmaceutical Design Meet Our Editorial Board Member
Recent Patents on Inflammation & Allergy Drug Discovery The Role of Adiponectin in Maintaining Metabolic Homeostasis
Current Diabetes Reviews Convection-Enhanced Delivery: Neurosurgical Issues
Current Drug Targets Vasoactive Factors and Diabetic Retinopathy: Vascular Endothelial Growth Factor, Cycoloxygenase-2 and Nitric Oxide
Current Pharmaceutical Design Reconceptualizing Adult Neurogenesis: Role for Sphingosine-1-Phosphate and Fibroblast Growth Factor-1 in Co-Ordinating Astrocyte-Neuronal Precursor Interactions
CNS & Neurological Disorders - Drug Targets Structural Features of the Interleukin-10 Family of Cytokines
Current Pharmaceutical Design Can Microbicides Turn the Tide Against HIV?
Current Pharmaceutical Design Antitumoral Activity of Interferon-γ Involved in Impaired Immune Function in Cancer Patients
Current Drug Metabolism Over-nutrition, Obesity and Insulin Resistance in the Development of β-Cell Dysfunction
Current Diabetes Reviews Cytotoxic and Allergenic Potential of Bioactive Proteins and Peptides
Current Pharmaceutical Design Biomarkers in Lone Atrial Fibrillation-An Additional ‘Fine Tuning’ of Risk?
Current Pharmaceutical Design Schistosoma mansoni Antigens as Modulators of the Allergic Inflammatory Response in Asthma
Endocrine, Metabolic & Immune Disorders - Drug Targets Potential Therapeutic Targeting of Platelet-Mediated Cellular Interactions in Atherosclerosis and Inflammation
Current Medicinal Chemistry The Dynamic TRPA1 Channel: A Suitable Pharmacological Pain Target?
Current Pharmaceutical Biotechnology Polyphenols Counteract Tumor Cell Chemoresistance Conferred by Multidrug Resistance Proteins
Anti-Cancer Agents in Medicinal Chemistry Vagal Stimulation Facilitates Improving Effects of Ranolazine on Cardiac Function in Rats with Chronic Ischemic Heart Failure
Current Molecular Medicine A Guide to Treatment of Sarcoidosis
Current Drug Therapy Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology